New consortium helps harmonise analysis of patient-reported outcomes and QOL data in cancer clinical trials
A new international multidisciplinary consortium, coordinated by EORTC, aims to [...]
EORTC Presentations at ISOQOL 2016 in Copenhagen
The EORTC will present 18 abstracts at the ISOQOL 2016 [...]
EORTC study published in NEJM shows prolonged survival in stage III melanoma
A randomized, phase 3 EORTC trial involving patients with resected, [...]
EORTC presentations at ENCR Scientific Meeting in Baveno, Italy Oct 5-7 2016
EORTC is conducting epidemiological outcome research, in partnership with population-based [...]
EORTC Presentations at ESMO 2016 Congress in Copenhagen
EORTC investigators will present the results of their cancer research [...]
Radiation or chemotherapy? Comparing survival, quality of life in patients with high-risk, low grade glioma
Results of a EORTC study (EORTC 22033-26033) recently published in [...]
EORTC partners with IBBL to support precision medicine clinical research
Brussels, Sept 27, 2016 EORTC and IBBL (Integrated BioBank of [...]
EORTC Expands Collaborative Agreement with Ignyta for Precision Medicine
EORTC, the European Organisation for Research and Treatment of Cancer, [...]
IBCD: First regulatory science meeting opens new doors for precision medicine
Last week, discussions at the Innovative Biomarkers for Cancer Drug [...]
EORTC study published in NEJM helps curb treatment in early-stage breast cancer, improve quality of life
The MINDACT study, managed by EORTC in partnership with BIG (Breast International [...]
